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Case description
A 10-year old mixed-breed domestic cat was presented for
a bone scintigraphy with a soft tissue tumour of one year duration.
The tumour, at the time of scintigraphic examination, was 4 cm in
diameter and was localized medially in the upper dorsum. Patho-
logic diagnosis based on fine needle biopsy was fibrosarcoma.
The aim of the scan was to assess the bone involvement with
eventual metastases prior to operation. Bone scanning was per-
formed in anterior, posterior and lateral projections using dual-
head gamma camera Multispect-2 (Siemens, Erlangen, Germa-
ny), 3 hours post-injection of 99mTc-MDP (OBRI-Polatom, Otwock,
Poland) of activity of 370 MBq.
The bone scan (Figure 1) revealed an accumulation of 99mTc-
-MDP in the primary tumour (arrow) and no pathological uptake in
bone structures. Intra-operational findings confirmed those data.
Commentary
Soft-tissue accumulation of osteotropic radiotracer was mainly
shown previously in metastases of primary osteosarcoma, both
in humans and animals [1–3] or in primary soft-tissue osteosar-
coma cases [4–7]. In this case, we showed a tracer accumulation
scintigraphically in a relatively rarely described tumour: primary
soft-tissue fibrosarcoma. Since both the diagnostic and therapeutic
radionuclides have the avidity to accumulate in osteosarcoma [8],
perhaps this might be of use in future for therapeutic purposes,
also in humans.
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Figure 1. Bone scan of a feline patient. Accumulation of radiotracer in
a primary fibrosarcoma pointed with arrow.
